340B Report Publisher and Chief Executive Officer Ted Slafsky tells 340B stakeholders in his latest column for Omnicell what to expect if Republicans take over Congress.

340B Report Publisher and CEO Forecasts What to Expect After November Congressional Elections

340B Report Publisher and Chief Executive Officer Ted Slafsky says in his latest column for Omnicell’s blog that “all signs foretell a Republican takeover of the House and a very good possibility of the GOP assuming control of the closely divided Senate” after the November 2022 elections for Congress.

“This will have significant implications for the 340B drug pricing program, not only for policy but also for the key players setting the agenda,” Slafsky says.

340B Report Publisher and Chief Executive Officer Ted Slafsky says in his latest column for Omnicell’s blog that “all signs foretell a Republican takeover of the House and a very good possibility of the GOP assuming control of the closely divided Senate” after the November 2022 elections for Congress.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer